RETRACTED ARTICLE: A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo
- DOI
- 10.1186/1471-2407-13-527
- Published
- 11
- Container
- BMC Cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
serious concern Score 18/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/1471-2407-13-527,
title = {RETRACTED ARTICLE: A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo},
author = {Yu-Yin Xu and Li Chen and Gui-Lan Wang and Jia-Ming Zhou and Yi-Xin Zhang and Yin-Ze Wei and Yuan-Yuan Zhu and Jing Qin},
year = {2013},
journal = {BMC Cancer},
doi = {10.1186/1471-2407-13-527},
url = {https://doi.org/10.1186/1471-2407-13-527}
}RIS
TY - JOUR TI - RETRACTED ARTICLE: A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo AU - Yu-Yin Xu AU - Li Chen AU - Gui-Lan Wang AU - Jia-Ming Zhou AU - Yi-Xin Zhang AU - Yin-Ze Wei AU - Yuan-Yuan Zhu AU - Jing Qin PY - 2013 JO - BMC Cancer DO - 10.1186/1471-2407-13-527 UR - https://doi.org/10.1186/1471-2407-13-527 ER -
APA
Xu, Y., Chen, L., Wang, G., Zhou, J., Zhang, Y., Wei, Y., Zhu, Y., & Qin, J. (2013). RETRACTED ARTICLE: A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo. BMC Cancer. https://doi.org/10.1186/1471-2407-13-527
Source records
- doaj · retrieved 2026-09-26T21:50:27.801Z